Company news

Protagonist Therapeutics, Inc. news in 2022

Protagonist Therapeutics, Inc.'s news releases, calls and decks from 2022, newest first.

View company

Protagonist Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference

December 20, 2022

Protagonist Therapeutics to Participate in the JMP Securities Hematology and Oncology Summit

November 30, 2022

Protagonist Reports Third Quarter 2022 Financial Results and Provides Corporate Update

November 7, 2022

Protagonist Therapeutics Announces Poster Presentations at the American Society of Hematology 2022 Annual Meeting

November 2, 2022

Protagonist Announces Appointment of Arturo Molina, M.D., M.S., F.A.C.P. as Chief Medical Officer

November 1, 2022

Protagonist Reports Second Quarter 2022 Financial Results and Provides Corporate Update

August 3, 2022

Protagonist Therapeutics to Participate at the Jefferies Healthcare Conference

May 31, 2022

Protagonist Therapeutics to Present Updated Phase 2 Rusfertide Clinical Results in Polycythemia Vera (PV) at ASCO 2022

May 25, 2022

Protagonist Reports First Quarter 2022 Financial Results and Provides Corporate Update

May 3, 2022

Protagonist Therapeutics Announces Topline Data from Phase 2 IDEAL Study of PN-943 in Ulcerative Colitis

April 24, 2022

Protagonist Therapeutics Announces Appointment of Asif Ali as Executive Vice President and Chief Financial Officer

March 27, 2022

Protagonist Therapeutics Earns $25 Million Milestone Payment from Janssen Biotech for Dosing of Third Patient in Phase 2b Clinical Trial of PN-235 in Moderate-to-Severe Plaque Psoriasis

March 15, 2022

Protagonist Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Corporate Update

February 27, 2022

Protagonist Therapeutics to Present at the 11th Annual SVB Leerink Global Healthcare Conference

February 9, 2022

Correction: Protagonist Therapeutics, Inc.

January 3, 2022

Decks in 2022